General Information of the Protein
Protein ID
PT00879
Protein Name
Proto-oncogene tyrosine-protein kinase Src
Secondarily
Protein Name
Proto-oncogene c-Src
pp60c-src
Gene Name
SRC
Secondarily
Gene Name
SRC1
Sequence
MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Kinase
>
Protein Kinase
>
TK protein kinase group
>
Tyrosine protein kinase Src family
Function
Non-receptor protein tyrosine kinase which is activated following engagement of many different classes of cellular receptors including immune response receptors, integrins and other adhesion receptors, receptor protein tyrosine kinases, G protein-coupled receptors as well as cytokine receptors. Participates in signaling pathways that control a diverse spectrum of biological activities including gene transcription, immune response, cell adhesion, cell cycle progression, apoptosis, migration, and transformation. Due to functional redundancy between members of the SRC kinase family, identification of the specific role of each SRC kinase is very difficult. SRC appears to be one of the primary kinases activated following engagement of receptors and plays a role in the activation of other protein tyrosine kinase (PTK) families. Receptor clustering or dimerization leads to recruitment of SRC to the receptor complexes where it phosphorylates the tyrosine residues within the receptor cytoplasmic domains. Plays an important role in the regulation of cytoskeletal organization through phosphorylation of specific substrates such as AFAP1. Phosphorylation of AFAP1 allows the SRC SH2 domain to bind AFAP1 and to localize to actin filaments. Cytoskeletal reorganization is also controlled through the phosphorylation of cortactin (CTTN) (Probable). When cells adhere via focal adhesions to the extracellular matrix, signals are transmitted by integrins into the cell resulting in tyrosine phosphorylation of a number of focal adhesion proteins, including PTK2/FAK1 and paxillin (PXN) (PubMed:21411625). In addition to phosphorylating focal adhesion proteins, SRC is also active at the sites of cell-cell contact adherens junctions and phosphorylates substrates such as beta-catenin (CTNNB1), delta-catenin (CTNND1), and plakoglobin (JUP). Another type of cell-cell junction, the gap junction, is also a target for SRC, which phosphorylates connexin-43 (GJA1). SRC is implicated in regulation of pre-mRNA-processing and phosphorylates RNA-binding proteins such as KHDRBS1 (Probable). Also plays a role in PDGF-mediated tyrosine phosphorylation of both STAT1 and STAT3, leading to increased DNA binding activity of these transcription factors (By similarity). Involved in the RAS pathway through phosphorylation of RASA1 and RASGRF1 (PubMed:11389730). Plays a role in EGF-mediated calcium-activated chloride channel activation (PubMed:18586953). Required for epidermal growth factor receptor (EGFR) internalization through phosphorylation of clathrin heavy chain (CLTC and CLTCL1) at 'Tyr-1477'. Involved in beta-arrestin (ARRB1 and ARRB2) desensitization through phosphorylation and activation of GRK2, leading to beta-arrestin phosphorylation and internalization. Has a critical role in the stimulation of the CDK20/MAPK3 mitogen-activated protein kinase cascade by epidermal growth factor (Probable). Might be involved not only in mediating the transduction of mitogenic signals at the level of the plasma membrane but also in controlling progression through the cell cycle via interaction with regulatory proteins in the nucleus (PubMed:7853507). Plays an important role in osteoclastic bone resorption in conjunction with PTK2B/PYK2. Both the formation of a SRC-PTK2B/PYK2 complex and SRC kinase activity are necessary for this function. Recruited to activated integrins by PTK2B/PYK2, thereby phosphorylating CBL, which in turn induces the activation and recruitment of phosphatidylinositol 3-kinase to the cell membrane in a signaling pathway that is critical for osteoclast function (PubMed:8755529, PubMed:14585963). Promotes energy production in osteoclasts by activating mitochondrial cytochrome C oxidase (PubMed:12615910). Phosphorylates DDR2 on tyrosine residues, thereby promoting its subsequent autophosphorylation (PubMed:16186108). Phosphorylates RUNX3 and COX2 on tyrosine residues, TNK2 on 'Tyr-284' and CBL on 'Tyr-731' (PubMed:20100835, PubMed:21309750). Enhances RIGI-elicited antiviral signaling (PubMed:19419966). Phosphorylates PDPK1 at 'Tyr-9', 'Tyr-373' and 'Tyr-376' (PubMed:14585963). Phosphorylates BCAR1 at 'Tyr-128' (PubMed:22710723). Phosphorylates CBLC at multiple tyrosine residues, phosphorylation at 'Tyr-341' activates CBLC E3 activity (PubMed:20525694). Phosphorylates synaptic vesicle protein synaptophysin (SYP) (By similarity). Involved in anchorage-independent cell growth (PubMed:19307596). Required for podosome formation (By similarity). Mediates IL6 signaling by activating YAP1-NOTCH pathway to induce inflammation-induced epithelial regeneration (PubMed:25731159). Phosphorylates OTUB1, promoting deubiquitination of RPTOR (PubMed:35927303).
    Show/Hide
Uniprot ID
Primary ID:
P12931

Secondarily ID:
E1P5V4
Q76P87
Q86VB9
Q9H5A8
    Show/Hide
Ensembl ID
ENSG00000197122
HGNC ID
HGNC:11283
Subcellular Location
Cell membrane
Mitochondrion inner membrane
Nucleus
Cytoplasm
Cytoskeleton
Cytoplasm
Perinuclear region
Cell junction
Focal adhesion
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000045 , A-375
Compound ID Compound Name Compound Formula
CP0672877
1-(3,3-Dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl)phenyl)urea
   Show/Hide
C23H29FN6O
 1
1
IC50 = 310 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0005166
BMS-354825
   Show/Hide
C22H26ClN7O2S
 12
1 IC50 = 0.21 nM
2 IC50 = 0.3 nM
3 IC50 = 0.4 nM
4 IC50 = 0.5 nM
5 IC50 = 0.6 nM
6 IC50 = 0.9 nM
7 IC50 < 1 nM
8 IC50 = 1 nM
9 IC50 = 1.5 nM
10 Kd = 0.21 nM
11 Kd = 11 nM
12 Ki = 0.016 nM
CP0075449
2,6,9-Trisubstitute purine, 6 (AP23464)
   Show/Hide
C26H30N5O2P
 2
1 IC50 = 0.45 nM
2 IC50 = 0.9 nM
CP0055838
3-[2-(4-amino-1-ethylpyrazolo[3,4-d]pyrimidin-3-yl)ethynyl]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide
   Show/Hide
C30H31F3N8O
 2
1 IC50 = 0.9 nM
2 IC50 = 30 nM
CP0061016
3-(4-Amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-phenol
   Show/Hide
C17H18N4O
 1
1 IC50 = 1 nM
CP0045281
AZD0530
   Show/Hide
C27H32ClN5O5
 3
1 IC50 = 1 nM
2 IC50 = 2.7 nM
3 IC50 = 3 nM
CP0156774
5-cyclopropyl-2-(3,5-dimethoxyanilino)-7-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]pyrazolo[1,5-a]pyrimidine-3-carboxamide
   Show/Hide
C27H30N6O4
 1
1 IC50 = 3 nM
CP0142470
US10266537, Compound 93
   Show/Hide
C29H27F3N6O2
 1
1 IC50 = 3 nM
CP0174031
N-(3-chloro-6-methoxypyridin-2-yl)-7-(3-morpholin-4-ylpropoxy)-5-propan-2-yloxyquinazolin-4-amine
   Show/Hide
C24H30ClN5O4
 1
1 IC50 < 4 nM
CP0174033
1-(4-(3-(4-(3-chloro-6-methoxypyridin-2-ylamino)-5-isopropoxyquinazolin-7-yloxy)propyl)piperazin-1-yl)ethanone
   Show/Hide
C26H33ClN6O4
 1
1 IC50 < 4 nM
CP0302966
N-(3-chloro-6-methoxypyridin-2-yl)-7-[3-(4-methylpiperazin-1-yl)propoxy]-5-propan-2-yloxyquinazolin-4-amine
   Show/Hide
C25H33ClN6O3
 1
1 IC50 < 4 nM
CP0079915
Benzodioxole deriv. 20
   Show/Hide
C23H25BrN4O5
 1
1 IC50 < 4 nM
CP0109656
BMCL182776 Compound 1
   Show/Hide
C24H27ClN4O4
 1
1 IC50 < 4 nM
CP0182891
Benzodioxole deriv. 19
   Show/Hide
C23H25ClN4O5
 1
1 IC50 < 4 nM
CP0109912
N-(2-chloro-5-methoxypyridin-3-yl)-7-(3-morpholin-4-ylpropoxy)-5-propan-2-yloxyquinazolin-4-amine
   Show/Hide
C24H30ClN5O4
 1
1 IC50 = 5 nM
CP0178748
N-(3-chloro-6-methoxypyridin-2-yl)-7-(3-morpholin-4-ylpropoxy)-5-(oxan-4-yloxy)quinazolin-4-amine
   Show/Hide
C26H32ClN5O5
 1
1 IC50 = 5 nM
CP0288470
5-cyclopropyl-2-(3,5-dimethoxyanilino)-7-[[(2S)-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]amino]pyrazolo[1,5-a]pyrimidine-3-carboxamide
   Show/Hide
C29H31N7O4
 1
1 IC50 = 5 nM
CP0339803
5-cyclopropyl-2-(3,5-dimethoxyanilino)-7-[[(2S)-1-hydroxy-3-pyridin-3-ylpropan-2-yl]amino]pyrazolo[1,5-a]pyrimidine-3-carboxamide
   Show/Hide
C26H29N7O4
 1
1 IC50 = 5 nM
CP0051681
AZD0530 analogue 34
   Show/Hide
C23H25ClN4O4
 1
1 IC50 = 5 nM
CP0174016
N-(3-chloro-6-methoxypyridin-2-yl)-5-propan-2-yloxy-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine
   Show/Hide
C24H30ClN5O3
 1
1 IC50 = 6 nM
CP0146333
N-(2-chloro-5-methoxypyridin-3-yl)-7-(3-morpholin-4-ylpropoxy)-5-(oxan-4-yloxy)quinazolin-4-amine
   Show/Hide
C26H32ClN5O5
 1
1 IC50 = 7 nM
CP0276783
N-(3-chloro-6-methoxypyridin-2-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-propan-2-yloxyquinazolin-4-amine
   Show/Hide
C24H31ClN6O3
 1
1 IC50 = 7 nM
CP0272327
1-(4-(2-(4-(3-chloro-6-methoxypyrazin-2-ylamino)-5-isopropoxyquinazolin-7-yloxy)ethyl)piperazin-1-yl)ethanone
   Show/Hide
C24H30ClN7O4
 1
1 IC50 = 8 nM
CP0422577
5-cyclopropyl-2-(3,5-dimethoxyanilino)-7-[[(2R)-1-hydroxy-3-methylbutan-2-yl]amino]pyrazolo[1,5-a]pyrimidine-3-carboxamide
   Show/Hide
C23H30N6O4
 1
1 IC50 = 8 nM
CP0059916
AZD0530 analogue 7
   Show/Hide
C27H33ClN4O5
 1
1 IC50 = 10 nM
CP0178750
1-(4-(2-(4-(3-chloro-6-methoxypyridin-2-ylamino)-5-isopropoxyquinazolin-7-yloxy)ethyl)piperazin-1-yl)ethanone
   Show/Hide
C25H31ClN6O4
 1
1 IC50 = 10 nM
CP0111947
Benzofuran deriv. 9
   Show/Hide
C24H25ClN4O4
 1
1 IC50 = 10 nM
CP0124502
Methoxy Aniline 5
   Show/Hide
C23H27ClN4O4
 1
1 IC50 = 10 nM
CP0200838
Benzofuran deriv. 11
   Show/Hide
C24H25ClN4O4
 1
1 IC50 = 10 nM
CP0267709
Benzodioxole deriv. 25
   Show/Hide
C22H23ClN4O4
 1
1 IC50 = 10 nM
CP0295734
4-[({4-[(5-chloro-2H-1,3-benzodioxol-4-yl)amino]-6-methoxyquinazolin-7-yl}oxy)methyl]pyridine-2-carbonitrile
   Show/Hide
C23H16ClN5O4
 1
1 IC50 = 10 nM
CP0686846
(2-Chloro-5-methoxy-phenyl)-[6-methoxy-7-(4-methyl-piperazin-1-ylmethoxy)-quinazolin-4-yl]-amine
   Show/Hide
C22H26ClN5O3
 1
1 IC50 = 10 nM
CP0284392
Benzodioxole deriv. 18
   Show/Hide
C23H26N4O5
 1
1 IC50 = 14 nM
CP0036121
N-(3-chloro-6-methoxypyridin-2-yl)-5-propan-2-yloxy-7-(2-pyrrolidin-1-ylethoxy)quinazolin-4-amine
   Show/Hide
C23H28ClN5O3
 1
1 IC50 = 15 nM
CP0135259
1-(4-(2-(4-(5-chloro-2-methoxypyrimidin-4-ylamino)-5-isopropoxyquinazolin-7-yloxy)ethyl)piperazin-1-yl)ethanone
   Show/Hide
C24H30ClN7O4
 1
1 IC50 = 15 nM
CP0443225
N-(2,6-dimethylphenyl)-5-[4-(2-pyrrolidin-1-ylethoxy)phenyl]imidazo[1,5-a]pyrazin-8-amine
   Show/Hide
C26H29N5O
 1
1 IC50 = 15 nM
CP0215554
N-(2,6-dimethylphenyl)-5-[3-[(1-methylpiperidin-3-yl)methoxy]phenyl]imidazo[1,5-a]pyrazin-8-amine
   Show/Hide
C27H31N5O
 1
1 IC50 = 19 nM
CP0496795
N-(3-chloro-6-methoxypyridin-2-yl)-7-(2-morpholin-4-ylethoxy)-5-propan-2-yloxyquinazolin-4-amine
   Show/Hide
C23H28ClN5O4
 1
1 IC50 = 20 nM
CP0201985
N-(2,6-dimethylphenyl)-5-[4-[(1-methylpiperidin-3-yl)methoxy]phenyl]imidazo[1,5-a]pyrazin-8-amine
   Show/Hide
C27H31N5O
 1
1 IC50 = 20 nM
CP0123552
Indole deriv. 17
   Show/Hide
C24H26ClN5O3
 1
1 IC50 = 20 nM
CP0166540
N-benzyl-2-[5-[4-(2-morpholin-4-ylethoxy)phenyl]pyridin-2-yl]acetamide
   Show/Hide
C26H29N3O3
 3
1 IC50 = 20 nM
2 IC50 = 67000 nM
3 IC50 > 20000 nM
CP0292172
Benzodioxole deriv. 21
   Show/Hide
C23H25FN4O5
 1
1 IC50 = 28 nM
CP0150295
N-[3-[[1-(6-aminopyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-3-chloro-4-[(4-ethylpiperazin-1-yl)methyl]benzamide
   Show/Hide
C32H34ClN9O
 1
1 IC50 = 32 nM
CP0078087
N-(5-chloro-2-methoxypyridin-4-yl)-7-(3-morpholin-4-ylpropoxy)-5-propan-2-yloxyquinazolin-4-amine
   Show/Hide
C24H30ClN5O4
 1
1 IC50 = 35 nM
CP0104018
N-(2,6-dimethylphenyl)-5-[4-(2-morpholin-4-ylethoxy)phenyl]imidazo[1,5-a]pyrazin-8-amine
   Show/Hide
C26H29N5O2
 1
1 IC50 = 37 nM
CP0183101
6-Methoxy-N-(3-methoxyphenyl)-7-(3-morpholin-4-ylpropoxy)quinazolin-4-amine
   Show/Hide
C23H28N4O4
 1
1 IC50 = 37 nM
CP0255394
AZD0530 analogue 10
   Show/Hide
C25H31ClN4O4
 1
1 IC50 = 40 nM
CP0112075
Benzodioxole deriv. 26
   Show/Hide
C23H25ClN4O5
 1
1 IC50 = 50 nM
CP0772308
N-(2,6-dimethylphenyl)-5-[5-(4-methylpiperazin-1-ylmethyl)thiophen-2-yl]imidazo[1,5-a]pyrazin-8-amine hydrochloride
   Show/Hide
C23H26ClN5S
 1
1 IC50 = 52 nM
CP0890115
N-(2,6-dimethylphenyl)-5-[3-(2-pyrrolidin-1-ylethoxy)phenyl]imidazo[1,5-a]pyrazin-8-amine hydrochloride
   Show/Hide
C26H30ClN5O
 1
1 IC50 = 55 nM
CP0147359
N-[3-[[1-(6-aminopyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-3-(4-ethylpiperazin-1-yl)-5-(trifluoromethyl)benzamide
   Show/Hide
C32H32F3N9O
 1
1 IC50 = 71 nM
CP0227161
N-[3-[[1-[6-[4-(diethylamino)butylamino]pyrimidin-4-yl]benzimidazol-2-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C34H37F3N8O
 1
1 IC50 = 97 nM
CP0289193
N-[4-methyl-3-[[1-[6-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]benzimidazol-2-yl]amino]phenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C34H36F3N9O
 1
1 IC50 = 128 nM
CP0147351
N-[3-[[1-(6-aminopyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-3-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)benzamide
   Show/Hide
C31H30F3N9O
 1
1 IC50 = 130 nM
CP0166278
N-[3-[[1-[6-[4-(dimethylamino)butylamino]pyrimidin-4-yl]benzimidazol-2-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C32H33F3N8O
 1
1 IC50 = 139 nM
CP0227163
N-[4-methyl-3-[[1-[6-(3-morpholin-3-ylpropylamino)pyrimidin-4-yl]benzimidazol-2-yl]amino]phenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C33H33F3N8O2
 1
1 IC50 = 165 nM
CP0339807
7-[(2-amino-2-methylpropyl)amino]-2-(3,5-dimethoxyanilino)-5-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide
   Show/Hide
C20H27N7O3
 1
1 IC50 = 175 nM
CP0289191
N-[3-[[1-(6-aminopyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-1-tert-butyl-5-[(4-methylpiperazin-1-yl)methyl]pyrazole-3-carboxamide
   Show/Hide
C32H39N11O
 1
1 IC50 = 177 nM
CP0230192
N-[3-[[1-(6-aminopyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-3-(1-methylpiperidin-4-yl)oxy-5-(trifluoromethyl)benzamide
   Show/Hide
C32H31F3N8O2
 1
1 IC50 = 233 nM
CP0150291
3-(1-(6-(4-(diethylamino)butylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-4-methyl-N-(3-(trifluoromethyl)phenyl)benzamide
   Show/Hide
C34H37F3N8O
 1
1 IC50 = 274 nM
CP0006184
6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione
   Show/Hide
C14H6O8
 1
1 IC50 = 300 nM
CP0893323
N-(2,6-dimethylphenyl)-5-(5-pyrrolidin-1-ylmethylthiophen-2-yl)imidazo[1,5-a]pyrazin-8-amine
   Show/Hide
C24H29ClN6S
 1
1 IC50 = 305 nM
CP0294208
N-[4-methyl-3-[[1-[6-[2-(4-methylpiperazin-1-yl)ethylamino]pyrimidin-4-yl]benzimidazol-2-yl]amino]phenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C33H34F3N9O
 1
1 IC50 = 305 nM
CP0007332
CHEMBL1276317
   Show/Hide
C19H17N3O4
 1
1 IC50 = 430 nM
CP0166375
N-[3-[[1-(6-aminopyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C26H20F3N7O
 1
1 IC50 = 450 nM
CP0150292
4-methyl-3-(1-(6-(2-(4-methylpiperazin-1-yl)ethylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-N-(3-(trifluoromethyl)phenyl)benzamide
   Show/Hide
C33H34F3N9O
 1
1 IC50 = 458 nM
CP0166281
3-(1-(6-(4-(dimethylamino)butylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-4-methyl-N-(3-(trifluoromethyl)phenyl)benzamide
   Show/Hide
C32H33F3N8O
 1
1 IC50 = 485 nM
CP0278790
4-methyl-3-(1-(6-(3-(4-methylpiperazin-1-yl)propylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-N-(3-(trifluoromethyl)phenyl)benzamide
   Show/Hide
C34H36F3N9O
 1
1 IC50 = 494 nM
CP0147358
N-[3-[[1-(6-aminopyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-3,5-dichlorobenzamide
   Show/Hide
C25H19Cl2N7O
 1
1 IC50 = 530 nM
CP0309083
N-[3-[[1-(6-aminopyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-5-tert-butylthiophene-2-carboxamide
   Show/Hide
C27H27N7OS
 1
1 IC50 = 916 nM
CP0166283
N-[3-[[1-(6-aminopyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-3-methylbenzamide
   Show/Hide
C26H23N7O
 1
1 IC50 = 1539 nM
CP0290298
N-[3-[[1-(6-aminopyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-3-chlorobenzamide
   Show/Hide
C25H20ClN7O
 1
1 IC50 = 1650 nM
CP0151357
N-[3-[[1-[6-(2-methoxyethylamino)pyrimidin-4-yl]benzimidazol-2-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C29H26F3N7O2
 1
1 IC50 = 1688 nM
CP0289530
CHEMBL1076473
   Show/Hide
C32H31F3N8O
 1
1 IC50 = 1722 nM
CP0268700
N-[3-[[1-[6-(2-hydroxyethylamino)pyrimidin-4-yl]benzimidazol-2-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C28H24F3N7O2
 1
1 IC50 = 1920 nM
CP0151356
N-[4-methyl-3-[[1-[6-(2-pyridin-2-ylethylamino)pyrimidin-4-yl]benzimidazol-2-yl]amino]phenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C33H27F3N8O
 1
1 IC50 = 2370 nM
CP0166284
N-[3-[[1-(6-aminopyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-5-tert-butyl-2-methylpyrazole-3-carboxamide
   Show/Hide
C27H29N9O
 1
1 IC50 = 7188 nM
CP0166376
N-[3-[[1-(6-aminopyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-5-cyclopropyl-1H-pyrazole-3-carboxamide
   Show/Hide
C25H23N9O
 1
1 IC50 = 7359 nM
CP0289192
N-[3-[[1-(6-chloropyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C26H18ClF3N6O
 1
1 IC50 = 16507 nM
CP0147360
N-[4-methyl-3-[[1-(6-morpholin-4-ylpyrimidin-4-yl)benzimidazol-2-yl]amino]phenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C30H26F3N7O2
 1
1 IC50 > 2500 nM
CP0150281
N-[4-methyl-3-[[1-[6-[(1-methylpiperidin-4-yl)amino]pyrimidin-4-yl]benzimidazol-2-yl]amino]phenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C32H31F3N8O
 1
1 IC50 > 2500 nM
CP0166282
3-(1-(6-amino-5-methylpyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-4-methyl-N-(3-(trifluoromethyl)phenyl)benzamide
   Show/Hide
C27H22F3N7O
 1
1 IC50 > 2500 nM
CP0166377
N-[3-[[1-(6-methoxypyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C27H21F3N6O2
 1
1 IC50 > 2500 nM
CP0289528
N-[4-methyl-3-[[1-[6-(2-pyrrolidin-2-ylethylamino)pyrimidin-4-yl]benzimidazol-2-yl]amino]phenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C32H31F3N8O
 1
1 IC50 > 2500 nM
CP0298947
N-[3-[[1-[6-[2-(diethylamino)ethylamino]pyrimidin-4-yl]benzimidazol-2-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C32H33F3N8O
 1
1 IC50 > 2500 nM
CP0012708
5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one
   Show/Hide
C15H10O5
 1
1 IC50 > 10000 nM
CP0661487
3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea monophosphate
   Show/Hide
C26H34Cl2N7O7P
 1
1 IC50 > 10000 nM
CP0002778
4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
   Show/Hide
C29H31N7O
 5
1 IC50 > 25000 nM
2 IC50 > 100000 nM
3 Kd = 39810.72 nM
4 Kd > 10000 nM
5 Ki = 31000 nM
CP0019908
BDBM50242742
   Show/Hide
C30H40ClN7O3S
 1
1 Kd = 280 nM
CP0002230
4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide
   Show/Hide
C28H22F3N7O
 1
1 Kd = 1900 nM
CP0157055
N-(3-bromophenyl)-6-methylsulfanyl-1-(2-phenylpropyl)pyrazolo[3,4-d]pyrimidin-4-amine
   Show/Hide
C21H20BrN5S
 2
1 Ki = 18 nM
2 Ki = 20 nM
CP0102858
1-[2-(4-bromophenyl)-2-chloroethyl]-N-phenylpyrazolo[3,4-d]pyrimidin-4-amine
   Show/Hide
C19H15BrClN5
 1
1 Ki = 64 nM
CP0126678
N-(3-bromophenyl)-1-(2-chloro-2-phenylethyl)-6-(2-morpholin-4-ylethylsulfanyl)pyrazolo[3,4-d]pyrimidin-4-amine
   Show/Hide
C25H26BrClN6OS
 1
1 Ki = 130 nM
CP0130713
1-(2-chloro-2-phenylethyl)-N-(3-chlorophenyl)-6-(methylthio)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
   Show/Hide
C20H17Cl2N5S
 3
1 Ki = 600 nM
2 Ki = 700 nM
3 Ki = 794.33 nM
CP0070258
N-benzyl-1-(2-chloro-2-phenylethyl)pyrazolo[3,4-d]pyrimidin-4-amine
   Show/Hide
C20H18ClN5
 3
1 Ki = 3000 nM
2 Ki = 3019.95 nM
3 Ki = 3162.28 nM
Clinical Information about the Protein
Target 1 ( Proto-oncogene c-Src (SRC) )
Target Type Successful Target
Disease 9 Target-related Diseases  9
1 Breast cancer [ICD-11: 2C60-2C65]
2 Chronic myelogenous leukaemia [ICD-11: 2A20.0]
3 Ischemia [ICD-11: 8B10-8B11]
4 Gastrointestinal cancer [ICD-11: 2C11]
5 Amyotrophic lateral sclerosis [ICD-11: 8B60.0]
6 Solid tumour/cancer [ICD-11: 2A00-2F9Z]
7 Brain cancer [ICD-11: 2A00]
8 Gram-positive bacterial infection [ICD-11: 1B74-1G40]
9 Nasopharyngeal carcinoma [ICD-11: 2B6B]
Approved Drug(s) 3 Approved Drugs  3
1 Bosutinib Approved
Breast cancer
2 Dasatinib Approved
Chronic myelogenous leukaemia
3 SKI-758 Approved
Ischemia
Clinical Trial Drug(s) 4 Clinical Trial Drugs  4
1 CP-868596 Phase 3
Gastrointestinal cancer
2 Masitinib Phase 3
Amyotrophic lateral sclerosis
3 Saracatinib Phase 2
Solid tumour/cancer
4 KX2-361 Phase 1
Brain cancer
Investigative Drug(s) 2 Investigative Drugs  2
1 HKI-9924129 Investigative
Gram-positive bacterial infection
2 PD173074 Investigative
Nasopharyngeal carcinoma
Similar Protein(s) and Bioactivity Statistics
90% Identity
Protein ID Protein Name Protein Organism
PT02255 Proto-oncogene tyrosine-protein kinase Src Mus musculus, Mouse
PT06144 Proto-oncogene tyrosine-protein kinase Src Rattus norvegicus, Rat
50% Identity
Protein ID Protein Name Protein Organism
PT01066 Tyrosine-protein kinase Yes Homo sapiens, Human
PT01342 Tyrosine-protein kinase Fgr Homo sapiens, Human